NovoCure Limited
DE ˙ DB ˙ JE00BYSS4X48
13,66 € ↑0,85 (6,63%)
2026-06-04
DEL PRIS
SecurityDE:038 / NovoCure Limited
InstitutionFifth Third Bancorp
Latest Disclosed Ownership2,500 shares
Latest Disclosed Value $ 27,250
Fifth Third Bancorp ownership in 038 / NovoCure Limited

On May 1, 2026 - Fifth Third Bancorp filed a 13F-HR form disclosing ownership of 2,500 shares of NovoCure Limited (DE:038) valued at $22,025 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 2,500 shares of NovoCure Limited. This represents a change in shares of 0.00% during the quarter. The current value of the position is $34,162 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-01 2026-03-31 13F NOVOCURE ORD SHS G6674U108 2,500 0 0.00 27 -15.62 0.0000
2026-02-02 2025-12-31 13F NOVOCURE ORD SHS G6674U108 2,500 0 0.00 32 0.00 0.0001
2025-11-07 2025-09-30 13F NOVOCURE ORD SHS G6674U108 2,500 0 0.00 32 -27.27 0.0001
2025-07-15 2025-06-30 13F NOVOCURE ORD SHS G6674U108 2,500 0 0.00 44 0.00 0.0002
2025-04-15 2025-03-31 13F NOVOCURE ORD SHS G6674U108 2,500 0 0.00 45 -40.54 0.0002
2025-01-21 2024-12-31 13F NOVOCURE ORD SHS G6674U108 2,500 0 0.00 74 89.74 0.0003
2024-10-17 2024-09-30 13F NOVOCURE ORD SHS G6674U108 2,500 0 0.00 39 -7.14 0.0001
2024-07-22 2024-06-30 13F NOVOCURE ORD SHS G6674U108 2,500 2,500 43 0.0002
2024-04-23 2024-03-31 13F NOVOCURE ORD SHS G6674U108 0 -1,000 -100.00 0 -100.00
2024-01-19 2023-12-31 13F NOVOCURE ORD SHS G6674U108 1,000 -254 -20.26 15 -30.00 0.0001
2023-10-31 2023-09-30 13F NOVOCURE ORD SHS G6674U108 1,254 -750 -37.43 20 -75.90 0.0001
2023-07-26 2023-06-30 13F NOVOCURE ORD SHS G6674U108 2,004 1,000 99.60 83 38.33 0.0004
2023-04-24 2023-03-31 13F NOVOCURE ORD SHS G6674U108 1,004 -2,231 -68.96 60 -74.68 0.0003
2023-01-25 2022-12-31 13F NOVOCURE ORD SHS G6674U108 3,235 896 38.31 237 33.15 0.0011
2022-10-25 2022-09-30 13F NOVOCURE ORD SHS G6674U108 2,339 1,293 123.61 178 143.84 0.0009
2022-08-04 2022-06-30 13F NOVOCURE ORD SHS G6674U108 1,046 0 0.00 73 -16.09 0.0004
2022-04-19 2022-03-31 13F NOVOCURE ORD SHS G6674U108 1,046 8 0.77 87 11.54 0.0004
2022-02-01 2021-12-31 13F NOVOCURE ORD SHS G6674U108 1,038 38 3.80 78 -32.76 0.0003
2021-10-15 2021-09-30 13F NOVOCURE ORD SHS G6674U108 1,000 -16 -1.57 116 -48.44 0.0005
2021-08-06 2021-06-30 13F NOVOCURE ORD SHS G6674U108 1,016 16 1.60 225 70.45 0.0010
2021-05-07 2021-03-31 13F NOVOCURE ORD SHS G6674U108 1,000 -2,921 -74.50 132 -80.53 0.0006
2021-02-16 2020-12-31 13F NOVOCURE ORD SHS G6674U108 3,921 1,270 47.91 678 129.83 0.0033
2020-11-09 2020-09-30 13F NOVOCURE ORD SHS G6674U108 2,651 270 11.34 295 109.22 0.0016
2020-08-05 2020-06-30 13F NOVOCURE ORD SHS G6674U108 2,381 1,218 104.73 141 80.77 0.0008
2020-05-05 2020-03-31 13F NOVOCURE ORD SHS G6674U108 1,163 158 15.72 78 -8.24 0.0006
2020-02-14 2019-12-31 13F NOVOCURE ORD SHS G6674U108 1,005 146 17.00 85 32.81 0.0005
2019-11-14 2019-09-30 13F NOVOCURE ORD SHS G6674U108 859 -913 -51.52 64 -42.86 0.0004
2019-08-07 2019-06-30 13F NOVOCURE ORD SHS G6674U108 1,772 318 21.87 112 60.00 0.0007
2019-05-14 2019-03-31 13F NOVOCURE ORD SHS G6674U108 1,454 578 65.98 70 141.38 0.0004
2019-02-14 2018-12-31 13F NOVOCURE ORD SHS G6674U108 876 13 1.51 29 -35.56 0.0002
2018-11-14 2018-09-30 13F NOVOCURE ORD SHS G6674U108 863 64 8.01 45 80.00 0.0003
2018-08-14 2018-06-30 13F NOVOCURE ORD SHS G6674U108 799 799 25 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.